ArticleDermatology and therapy2026
Six-Month Changes in Periorbital and Perioral Wrinkles and Facial Skin Quality following Low-Cross-Linked Hyaluronic Acid.
Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFine wrinkles in the periorbital and perioral regions present therapeutic challenges because of thin dermal structure and high mobility. In these delicate facial areas, high-G' fillers may be limited by concerns regarding superficial placement and palpability, whereas non-cross-linked boosters often provide only short-lived effects. Low-G' hyaluronic acid formulations with favorable cohesivity, low complex viscosity, and high water affinity were developed to improve durability while maintaining flexibility suitable for intradermal treatment in thin, highly dynamic facial regions.
methodsThis observational study enrolled 25 subjects with facial wrinkles (Wrinkle Severity Rating Scale [WSRS] ≥ 2) who received three sessions of intradermal microinjections at 4-week intervals and were followed for 24 weeks to evaluate efficacy, durability, and safety. Outcomes included changes in wrinkle severity, global aesthetic improvement, objective skin quality parameters, and ultrasound-based dermal measurements.
resultsBy week 24, mean WSRS scores decreased from 3.06 ± 0.51 to 1.79 ± 0.45 in the periorbital region and from 3.18 ± 0.49 to 2.01 ± 0.46 in the perioral region, with earlier improvement observed in the periorbital area and more gradual changes in the perioral area. Global Aesthetic Improvement Scale (GAIS) demonstrated improvement in 81.8% of subjects by investigator assessment and 86.4% by subject assessment. Objective measures showed significant changes in elasticity, surface texture, hydration-related indices, and transepidermal water loss, along with increased dermal thickness and echogenicity on ultrasound. No serious adverse events were observed over the 24-week period.
conclusionsThese findings support the potential utility of low-G' hyaluronic acid with favorable cohesivity, low complex viscosity, and high-water affinity as a treatment option for fine wrinkles in thin, highly dynamic facial regions. The observed improvement across clinical, biophysical, and ultrasound-based measures suggests a broader contribution to skin quality enhancement beyond wrinkle correction alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.